Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
100%
Neoplasm
94%
Metastatic Colorectal Cancer
70%
Non Insulin Dependent Diabetes Mellitus
59%
Circulating Tumor DNA
55%
Overall Survival
55%
Ovary Cancer
50%
Chemotherapy
48%
Progression Free Survival
43%
Colorectal Cancer
43%
Epidermal Growth Factor Receptor
42%
Malignant Neoplasm
42%
Breast Cancer
40%
Disease
36%
Bevacizumab
30%
Non Small Cell Lung Cancer
29%
Irinotecan
28%
Vitamin D
25%
Cohort Study
23%
Prostate Cancer
21%
Vasculotropin
20%
Hydrocortisone
20%
All Cause Mortality
20%
Ovary Carcinoma
19%
microRNA
18%
Recurrent Disease
18%
Ovary Tumor
17%
Placebo
17%
Metastasis
17%
Randomized Controlled Trial
17%
Chemoradiation Therapy
16%
Diabetes Mellitus
16%
Rectum Cancer
16%
Phase II Trials
16%
Cetuximab
14%
Prevalence
13%
Adverse Event
13%
Metformin
13%
Anticoagulant Agent
12%
Urokinase Receptor
12%
Receptor
11%
Rheumatoid Arthritis
11%
Epidermal Growth Factor
11%
25 Hydroxyvitamin D
11%
Enzyme-Linked Immunosorbent Assay
10%
Lung Cancer
10%
Combination Therapy
10%
Gamma Interferon
10%
Carboplatin
9%
Ethylenediaminetetraacetic Acid
9%
Symptom
9%
Capecitabine
9%
Complement Component C3d
9%
Erythema
8%
Infection
8%
Bone Metastasis
8%
Creatinine
8%
SARS Coronavirus
8%
C Reactive Protein
8%
Comorbidity
8%
Cefuroxime
8%
Urinary Tract Infection
8%
Alpha Tocotrienol
8%
Biliary Tract Cancer
8%
Colon Cancer
8%
Disseminated Cancer
8%
Platelet Derived Growth Factor
8%
Warfarin
8%
Acetylsalicylic Acid
8%
Human Epididymis Protein 4
8%
Mannose Binding Lectin
8%
Prothrombin
8%
Gemcitabine
8%
Neuropeptide Y
7%
8 Hydroxydeoxyguanosine
7%
Epidermal Growth Factor Receptor 2
7%
Solid Malignant Neoplasm
7%
Inflammation
7%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase Inhibitor
6%
Vasculotropin A
6%
Oxaliplatin
6%
Tumor Marker
6%
Metastatic Breast Cancer
6%
Pharmacogenomics
6%
Glucagon Like Peptide 1 Receptor Agonist
6%
Cross-Sectional Study
6%
Prospective Study
6%
Nucleic Acid
5%
Cortisone
5%
Cardiovascular Mortality
5%
Monotherapy
5%
Spondylarthritis
5%
Intervention Study
5%
Zoledronic Acid
5%
Castration Resistant Prostate Cancer
5%
Pembrolizumab
5%
Disease Marker
5%
Tumor Necrosis Factor Inhibitor
5%
Biochemistry, Genetics and Molecular Biology
Circulating Tumor DNA
54%
Genome-Wide Association Study
53%
Overall Survival
51%
Prevalence
45%
Genetics
42%
Epidermal Growth Factor Receptor
41%
Single-Nucleotide Polymorphism
39%
Allele
37%
Reference Value
33%
Progression Free Survival
32%
Lipid
32%
MicroRNA
30%
Genotyping
30%
Osteoclast
28%
Genetic Divergence
28%
Blood Pressure
28%
HOXA9
25%
Blood Level
24%
Methylation
24%
Cohort Study
23%
Minor Allele Frequency
23%
Exome
23%
Alpha Oxidation
21%
Myeloid
21%
Vascular Endothelial Growth Factor
20%
Osteolysis
20%
Natural Killer Cell
20%
DNA Methylation
20%
RNA
19%
Tumor Necrosis Factor
19%
Eicosanoid Receptor
18%
Comorbidity
18%
Body Mass
18%
Real-Time Polymerase Chain Reaction
18%
KRAS
17%
All Cause Mortality
17%
Stem Cell
17%
Homeobox
16%
Bevacizumab
16%
Urine Sampling
15%
Droplet Digital Polymerase Chain Reaction
15%
Glucose Metabolism
14%
Liquid
13%
Blood Lipids
13%
Oxidative Stress
12%
Glycosylated Hemoglobin
12%
Sex Hormone-Binding Globulin
12%
Urinary Excretion
12%
Clinical Trial
12%
Missense
11%
Population Research
11%
Glucose Blood Level
11%
Nucleic Acid
11%
Vitamin Blood Level
11%
Single Nucleotide Polymorphism
10%
Artificial Intelligence
10%
Glucose Test
10%
Glucose Tolerance Test
10%
Neurofilament
10%
Light Chain
10%
Epidermal Growth Factor
10%
Cortisol
10%
Tumor Necrosis Factor Alpha
10%
Case-Control Study
10%
Creatinine
10%
Deoxyguanosine
10%
Multivariate Analysis
10%
Genetic Variation
10%
Genetic Architecture
10%
Exome Sequencing
10%
Insulin Release
10%
Insulin Sensitivity
9%
Vascular Endothelial Growth Factor A
9%
Cell Function
9%
Triglyceride
9%
Polymerase Chain Reaction
9%
Proteomics
9%
Metabolite
9%
Prospective Cohort Study
9%
Interferon Gamma
9%
Cholesterol Blood Level
9%
Progeny
9%
Dynamics
9%
Surface Property
9%
Cell Activity
9%
Flow Cytometry
9%
C-Type Lectin
9%
Glycated Hemoglobin
8%
Mir-126
8%
Capecitabine
8%
Lipid Level
8%
Colon
8%
Beta-2 Microglobulin
8%
Cross Sectional Study
8%
Growth Factor-Like Domain
8%
Messenger RNA
8%
Lectin Binding
8%
Mannose
8%
Epigenome
8%
Urokinase Receptor
8%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
61%
Biological Marker
54%
Diagnosis
44%
Ovarian Cancer
43%
Colorectal Cancer
40%
Neoplasm
37%
Disease
37%
Cell-Free DNA
33%
Malignant Neoplasm
29%
Diabetes
29%
Breast Cancer
28%
Circulating Tumor DNA
27%
Overall Survival
26%
Meta-Analysis
23%
Systematic Review
20%
Polycystic Ovary Syndrome
20%
Vitamin D
20%
Diagnostic Accuracy
19%
Placebo
19%
Krukenberg Tumor
18%
Specific Tumor
18%
Emergency Department
18%
Rectum Cancer
18%
Personalized Medicine
17%
Ovarian Tumor
17%
Non Small Cell Lung Cancer
16%
Hydrocortisone
16%
Prostate Cancer
16%
Epidermal Growth Factor Receptor
16%
Chemoradiotherapy
16%
Progression Free Survival
14%
Diabetes Mellitus
14%
Third Trimester Pregnancy
13%
Randomized Controlled Trial
13%
Glycon
13%
Stem Cell
13%
Metastatic Colorectal Cancer
13%
Methylation
12%
Lung Cancer
12%
Genome Wide Association Study
12%
Prevalence
12%
Supplementation
12%
Bevacizumab
12%
Vasculotropin
12%
Human Epididymis Protein 4
12%
Flow Cytometry
11%
Cancer
11%
Prognostic Factor
11%
microRNA
11%
Hazard Ratio
10%
Infection
10%
CA-125
10%
Symptom
10%
Cross Sectional Study
10%
Urine Sampling
9%
Cohort Analysis
9%
Recurrent Disease
9%
Metastatic Carcinoma
9%
Irinotecan
9%
Acute Myeloid Leukemia
9%
Child
9%
C Reactive Protein
9%
Quality of Life
9%
Insulin Dependent Diabetes Mellitus
9%
Targeted Therapy
9%
Mass Spectrum
8%
Bone Metastasis
8%
DNA Methylation
8%
Reproducibility
8%
Multivariate Analysis
8%
Single Nucleotide Polymorphism
8%
Adverse Event
8%
Health Care
8%
Severe Acute Respiratory Syndrome Coronavirus 2
8%
Treatment Response
8%
Bacteriuria
8%
Diagnostic Performance
8%
Anticoagulant Therapy
8%
Bleeding
8%
Gemcitabine
8%
Chronic Fatigue Syndrome
8%
Laboratory Medicine
8%
Capecitabine
8%
Biliary Tract Cancer
8%
Urinary Tract Infection
8%
Brain Metastasis
8%
Urokinase Receptor
8%
Intoxication
8%
Proteomics
8%
Platelet Derived Growth Factor
8%
Inflammatory Disorder
8%
Recurrent Ovarian Cancer
8%
Medicine
8%
Homeobox
8%
Myeloproliferative Neoplasm
8%
Gamma Urogastrone
8%
Epidermal Growth Factor Receptor 2
8%
Minimal Residual Disease
8%
Natural Killer Cell
8%
Magnetic Resonance Imaging
8%